Patents by Inventor Daniel STAMER

Daniel STAMER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RNAi therapy for treatment and/or prevention of glaucoma
    Patent number: 12054719
    Abstract: The present invention is directed to an RNAi-inducing agent capable of reducing and/or inhibiting the expression of proteins associated with the tight junction complex joining Schlemm's canal endothelial cells (SCEC) in the eye of a subject for use in the prevention and/or treatment of glaucoma. Specifically, the RNAi-inducing agent is capable of reducing and/or inhibiting the expression of proteins expressed in the tight junction complex or supporting the tight junction complex joining Schlemm's canal endothelial cells (SCEC) in the eye of a subject for use in the prevention and/or treatment of glaucoma. Methods using this RNAi-inducing agent are also contemplated.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: August 6, 2024
    Assignees: PROV FELLOWS COLLEGE HOLY TRINITY QUEEN ELIZABETH, IMPERIAL COLLEGE INNOVATIONS LIMITED, DUKE UNIVERSITY
    Inventors: Peter Humphries, Marian Humphries, Matthew Campbell, Anna-Sophia Kiang, Daniel Stamer, Darryl Ray Overby, Chi Shing Lawrence Tam
  • RNAi Therapy for Treatment and/or Prevention of Glaucoma
    Publication number: 20190376065
    Abstract: The present invention is directed to an RNAi-inducing agent capable of reducing and/or inhibiting the expression of proteins associated with the tight junction complex joining Schlemm's canal endothelial cells (SCEC) in the eye of a subject for use in the prevention and/or treatment of glaucoma. Specifically, the RNAi-inducing agent is capable of reducing and/or inhibiting the expression of proteins expressed in the tight junction complex or supporting the tight junction complex joining Schlemm's canal endothelial cells (SCEC) in the eye of a subject for use in the prevention and/or treatment of glaucoma. Methods using this RNAi-inducing agent are also contemplated.
    Type: Application
    Filed: April 28, 2017
    Publication date: December 12, 2019
    Inventors: Peter HUMPHRIES, Marian HUMPHRIES, Matthew CAMPBELL, Anna-Sophia KIANG, Daniel STAMER, Darryl Ray OVERBY, Chi Shing Lawrence TAM